Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR35 | Q9HC97 | 2/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.53 |
| ▸ | MEN1 | O00255 | 2/20 | 0.53 |
| ▸ | TSHR | P16473 | 1/20 | 0.52 |
| ▸ | CA1 | P00915 | 1/20 | 0.50 |
| ▸ | CA2 | P00918 | 1/20 | 0.50 |
| ▸ | MMP1 | P03956 | 1/20 | 0.50 |
| ▸ | MMP2 | P08253 | 1/20 | 0.50 |
| ▸ | MMP9 | P14780 | 1/20 | 0.50 |
| ▸ | MMP8 | P22894 | 1/20 | 0.50 |
| ▸ | MMP13 | P45452 | 1/20 | 0.50 |
| ▸ | F2 | P00734 | 3/20 | 0.46 |
| ▸ | PRSS1 | P07477 | 3/20 | 0.46 |
| ▸ | PRSS2 | P07478 | 3/20 | 0.46 |
| ▸ | PRSS3 | P35030 | 3/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.45 |
| ▸ | S100A4 | P26447 | 1/20 | 0.43 |
| ▸ | THRB | P10828 | 1/20 | 0.43 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL318287 | 1.00 | GPR35 (0.56) | GPR35KMT2AMEN1TSHRCA1 | |
| Hydrochloric Acid SCHEMBL11753998 | 0.98 | GPR35 (0.55) | GPR35KMT2AMEN1TSHRCA1 | |
| Methylamine SCHEMBL8582028 | 0.95 | GPR35 (0.51) | GPR35KMT2AMEN1TSHRCA1 | |
| SCHEMBL3193995 | 0.85 | KMT2A (0.68) | GPR35KMT2AMEN1TSHRCA1 | |
| Sulfuric Acid SCHEMBL220862 | 0.84 | GPR35 (0.64) | GPR35KMT2AMEN1TSHRCA1 | |
| SCHEMBL195393 | 0.83 | GPR35 (0.44) | GPR35KMT2AMEN1TSHRCA1 | |
| SCHEMBL26980 | 0.83 | GPR35 (0.44) | GPR35KMT2AMEN1TSHRCA1 | |
| SCHEMBL6846085 | 0.83 | KMT2A (0.55) | GPR35KMT2AMEN1CA1CA2 | |
| SCHEMBL6846086 | 0.83 | KMT2A (0.55) | GPR35KMT2AMEN1CA1CA2 | |
| SCHEMBL27464031 | 0.83 | GPR35 (0.44) | GPR35KMT2AMEN1TSHRCA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 814 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024256789-A1 | IN VITRO MODEL OF INFLAMED INTESTINAL BARRIER | UNIVERSITE DE FRANCHE COMTE (FR) | 2024-12-19 | — | — | WO | claimed |
| WO-2023136603-A1 | AVATAR MODEL SIMULATING IMMUNE SYSTEM OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE, AND DRUG SCREENING PLATFORM | 가톨릭대학교 산학협력단 | 2023-07-20 | — | — | WO | claimed |
| CN-116349679-A | Composite disinfection and sterilization method | 孙国明 | 2023-06-30 | — | — | CN | claimed |
| WO-2022158882-A1 | INTESTINAL ORGANOID IMMUNE-CONTROL INTEGRATED PLATFORM FOR THERAGNOSIS OF MICROBIOME AND IMMUNE CELL | 가톨릭대학교 산학협력단 | 2022-07-28 | — | — | WO | claimed |
| US-10556909-B2 | Synthetic process and intermediates | AVISTA PHARMA SOLUTIONS, INC. (US) | 2020-02-11 | — | — | US | claimed |
| US-20190284199-A1 | Synthetic Process and Novel Intermediates | BLUE OWL CAPITAL CORPORATION, AS NEW AGENT | 2019-09-19 | — | — | US | claimed |
| CN-110079403-A | A kind of energy saving and environment friendly gunpowder residue cleaning agent | 武汉硕隽科技有限公司 | 2019-08-02 | — | — | CN | claimed |
| CN-109879545-A | A kind of high saliferous, concentration organic wastewater disposal process and method | 北京丰泽绿源环境技术有限公司 | 2019-06-14 | — | — | CN | claimed |
| EP-3365168-A1 | LIGHTWEIGHT FLAME RETARDANT THERMOPLASTIC STRUCTURES | Schneller, LLC (US) | 2018-08-29 | — | — | EP | claimed |
| CN-108396564-A | A kind of disperse type cationic dye aqueous color paste and preparation method thereof | 郑州鸿盛数码科技股份有限公司 | 2018-08-14 | — | — | CN | claimed |
| WO-1999009111-A1 | ELECTROCHROMIC SYSTEM WITH COUPLED RED-OX SYSTEM AND SPECIAL ANIONS | BAYER AKTIENGESELLSCHAFT (DE) | 1999-02-25 | — | — | WO | claimed |
| US-5639928-A | ADDING RESIDUE INHIBITING AMOUNT OF NITRO OR NITROSO SUBSTITUTED PHENOL OR SULFONIC ACID | ARCO CHEMICAL TECHNOLOGY, L.P. (US) | 1997-06-17 | — | — | US | claimed |
| CN-1124012-A | Arylating medicaments | RADOPATH LTD (GB) | 1996-06-05 | — | — | CN | claimed |
| EP-0700287-A1 | ARYLATING MEDICAMENTS | RADOPATH LIMITED (GB) | 1996-03-13 | — | — | EP | claimed |
| WO-1994027584-A2 | ARYLATING MEDICAMENTS | RADOPATH LIMITED (GB) | 1994-12-08 | — | — | WO | claimed |
| US-4708744-A | BROMATE AND NITROAROMATIC ACCELERATOR | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 1987-11-24 | — | — | US | claimed |
| US-4186008-A | STRONG ACID, WATER-SOLUBLE IODIDE, NON-QUATERNIZED QUINOXALINE OR PYRAZINE, ANIT-OXIDANT, QUATERNARY AMMONIUM SALT OF AMINE SALT | CIBA-GEIGY AKTIENGESELLSCHAFT (CH) | 1980-01-29 | — | — | US | claimed |
| US-4171976-A | Homopolymerization inhibition of photographic hardeners | EASTMAN KODAK COMPANY (US) | 1979-10-23 | — | — | US | claimed |
| US-4066395-A | CATIONIC DYES | CIBA-GEIGY CORPORATION (US) | 1978-01-03 | — | — | US | claimed |
| US-4014698-A | ACIDS, IODIDE COMPOUNDS, OXIDIZERS, DIAZINE COMPOUND | CIBA-GEIGY AG (CH) | 1977-03-29 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190284199-A1 | Synthetic Process and Novel Intermediates | SBDS, LSS, NISCH | GPR35 3754/4885KMT2A 4118/4885MEN1 2742/4885 |
| US-10556909-B2 | Synthetic process and intermediates | SBDS, NISCH, SQOR | GPR35 4059/4885KMT2A 4217/4885MEN1 2686/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.